SCHEMBL5955203

SCHEMBL5955203

CC(NO)c1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 9/20 0.56
▸ ESR2 Q92731 8/20 0.56
▸ PDCD1 Q15116 1/20 0.56
▸ CD274 Q9NZQ7 1/20 0.56
▸ LMNA P02545 3/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ CYP2D6 P10635 2/20 0.44
▸ SLC6A2 P23975 2/20 0.44
▸ ADRA1A P35348 2/20 0.44
▸ OPRM1 P35372 2/20 0.44
▸ SLC6A3 Q01959 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ PGR P06401 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ AR P10275 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18551584 0.80 ESR1 (0.56) ESR1ESR2PDCD1CD274LMNA
SCHEMBL7773053 0.80 SMN1; SMN2 (0.41) LMNATDP1MAPTKDM4ESMN1; SMN2
SCHEMBL12318248 0.80 ESR1 (0.56) ESR1ESR2PDCD1CD274LMNA
SCHEMBL9912163 0.80 ESR1 (0.56) ESR1ESR2PDCD1CD274LMNA
SCHEMBL14305054 0.80 SMN1; SMN2 (0.41) LMNATDP1MAPTKDM4ESMN1; SMN2
SCHEMBL14281851 0.78 ESR1 (0.54) ESR1ESR2PDCD1CD274LMNA
SCHEMBL6168684 0.78 HTT (0.50) LMNACYP2C9CYP3A4CYP2D6CYP2C19
SCHEMBL3984623 0.77 TDP1 (0.48) LMNACYP2C9TDP1CYP3A4ALOX15
SCHEMBL3044206 0.77 TDP1 (0.48) LMNACYP2C9TDP1CYP3A4ALOX15
SCHEMBL3984108 0.77 TDP1 (0.48) LMNACYP2C9TDP1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692096-A1 HYDROXYLAMINE DERIVATIVES Newron Pharmaceuticals S.p.A. (IT) 2006-08-23 — — EP claimed
WO-2005058800-A1 HYDROXYLAMINE DERIVATIVES NEWRON PHARMACEUTICALS S.P.A. (IT) 2005-06-30 — — WO claimed
EP-1692096-A1 HYDROXYLAMINE DERIVATIVES Newron Pharmaceuticals S.p.A. (IT) 2006-08-23 — — EP disclosed
WO-2005058800-A1 HYDROXYLAMINE DERIVATIVES NEWRON PHARMACEUTICALS S.P.A. (IT) 2005-06-30 — — WO disclosed
Send feedback